Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Utility of tumor marker levels in predicting survival of patients with appendiceal adenocarcinoma.
Authors
Abdelrahman M.G. Yousef
University of Texas MD Anderson Cancer Center, Houston, TX;
Abdelrahman M.G. Yousef , Aditya More , Mohammad A. Zeineddine , Saikat Chowdhury , Yue Gu , Julia Dansby , Zahra Alavi Naini , Abhineet Uppal , Kanwal Pratap Singh Raghav , Michael J. Overman , Keith F. Fournier , John Paul Y.C. Shen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 221)
DOI
10.1200/JCO.2023.41.4_suppl.221
Abstract #
221
Poster Bd #
M3
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Serum tumor marker utilization in patients with advanced solid tumors.
First Author: Melissa Kate Accordino
Poster
2015 Gastrointestinal Cancers Symposium
S100P tumor-marker response to chemotherapy in patients with advanced pancreatic cancer.
First Author: Shuichi Mitsunaga
Poster
2013 Genitourinary Cancers Symposium
Pre-cystectomy serum levels of CA19-9, CA125, and CEA: Correlation with pathologic stage and oncologic outcome in urothelial carcinoma of bladder.
First Author: Hamed Ahmadi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy vs upfront resection: A challenging choice in resectable pancreatic ductal adenocarcinoma.
First Author: Fatemeh Fekrmandi